European Journal of Biology

SUBMITINFORMATION
EnglishTürkçe

Research Article


DOI :10.26650/EurJBiol.2019.0006   IUP :10.26650/EurJBiol.2019.0006    Full Text (PDF)

Lectin Treatment Affects Malignant Characteristics of TPC-1 Papillary Thyroid Cancer Cells

Aylin Sancaklı, Engin Kaptan

Objective: Abnormal glycosylation is a universal aspect of cancer cells. The altered glycosylation pattern has been originated from changings in expression of glycosylation enzymes which are up-regulating in reply to some oncoproteins in the biosynthetic pathway of glycans. In this study, it was aimed to show the presence of terminal α-2,3, α-2,6 sialic acid and α-1,6/α-1,2 fucose motifs in TPC-1 papillary thyroid cancer cells. Also it was aimed to examine the changes in viability and mobility of the cells after exogenously specific lectin treatment. Materials and Methods: In this study, the presence of terminal sugar residues in glycan chains on the cell surface was demonstrated using lectin histochemistry and lectin blotting techniques in TPC-1 cells. The changes in the cell viability and proliferation after lectin treatment were assessed using the WST-1 test. The Changes in the cell mobility after lectin treatment, however, were assessed using the wound healing test. Results: α-2,3, α-2,6 sialic acid and α-1,6/α-1,2 fucose motifs were widespread in the surface of TPC-1 cells. MAL-II (Maackia amurensis Lectin II) treatment increased the cell proliferation and mobility of TPC-1 cells. Although SNA (Sambucus nigra Aglutinin) and AAL (Aleuria aurantia Lectin) treatment did not significantly affect the cell proliferation, SNA and AAL treatment supported the mobility of TPC-1 cells. Conclusion: Lectin treatment affect cancerous properties differently depending on the cell type. Also lectin treatment can support the malignant behaviour of cancer. For this reason, it is necessary to understand the mechanisms of the lectin effect on the cancer cells.
Keywords: Papillary thyroid cancer, lectin treatment, glycosylation

PDF View

References

  • 1. Xing M. Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer 2013; 13(3):184-99. google scholar
  • 2. Catalano MG, Poli R, Pugliese M, Fortunati N, Boccuzzi G. Emerging molecular therapies of advanced thyroid cancer. Mol Aspects Med 2010; 31(2): 215-26. google scholar
  • 3. KondoT, Ezzat S, Asa SL. Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 2006; 6(4): 292-306. google scholar
  • 4. Xing M. Prognostic utility of BRAF mutation in papillary thyroid cancer. Mol Cell Endocrinol 2010; 321(1): 86-93. google scholar
  • 5. Nucera C, Lawler J, Hodin R, Parangi S. The BRAFV600E mutation: what is it really orchestrating in thyroid cancer? Oncotarget 2010; 1(8): 751-6. google scholar
  • 6. Janknecht R. On the road to immortality: hTERT upregulation in cancer cells. FEBS Lett 2004; 564(1-2): 9-13. google scholar
  • 7. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE,. Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279(5349): 349-52. google scholar
  • 8. Hrdličková R, Nehyba J, Bose HR. Alternatively spliced telomerase reverse transcriptase variants lacking telomerase activity stimulate cell proliferation. Mol Cell Biol 2012; 32(21): 4283-96. google scholar
  • 9. Sarin KY, Cheung P, Gilison D, Lee E, Tennen RI, Wang E, Artandi MK, Oro AE, Artandi SE. Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature 2005; 436(7053): 1048-52 google scholar
  • 10. Reinders J, Sickmann A. Modificomics: posttranslational modifications beyond protein phosphorylation and glycosylation. Biomol Eng 2007; 24(2): 169-77. google scholar
  • 11. Freeze HH, Chong JX, Bamshad MJ, Ng BG. Solving glycosylation disorders: fundamental approaches reveal complicated pathways. Am J Hum Genet 2014; 94(2): 161-75. google scholar
  • 12. Schultz MJ, Swindall AF, Bellis SL. Regulation of the metastatic cell phenotype by sialylated glycans. Cancer Metastasis Rev 2012; 31(3-4): 501-18. google scholar
  • 13. Reis CA, Osorio H, Silva L, Gomes C, David L. Alterations in glycosylation as biomarkers for cancer detection. J Clin Pathol 2010; 63(4): 322-9. google scholar
  • 14. A. Varki, R. Kannagi, and B. P. Toole, “Glycosylation changes in cancer” in Essentials of Glycobiology, A. Varki, R. D. Cummings, J. D. Esko et al., Eds., 2009. google scholar
  • 15. Meany DL, Chan DW. Aberrant glycosylation associated with enzymes as cancer biomarkers. Clin Proteom 2011; 8(1): 7. google scholar
  • 16. Martin LT, Marth JD, Varki A, Varki NM. Genetically altered mice with different sialyltransferase deficiencies show tissue-specific alterations in sialylation and sialic acid 9-O-acetylation. J Biol Chem 2002; 277(36): 32930-8. google scholar
  • 17. De Mejía, E.G. and Prisecaru, V.I., (2005). Lectins as bioactive plant proteins: a potential in cancer treatment. Crit Rev Food Sci Nutr 45(6): 425-45. google scholar
  • 18. Ryder SD, Smith JA, Rhodes JM. Peanut lectin: a mitogen for normal human colonic epithelium and human HT29 colorectal cancer cells. J Natl Med Assoc 1992; 84(18): 1410-6. google scholar
  • 19. Singh R, Subramanian S, Rhodes JM, Campbell BJ. Peanut lectin stimulates proliferation of colon cancer cells by interaction with glycosylated CD44v6 isoforms and consequential activation of c-Met and MAPK: functional implications for disease-associated glycosylation changes. Glycobiology 2006; 16(7): 594-601. google scholar
  • 20. Mehta S, Chhetra R, Srinivasan R, Sharma SC, Behera D. Ghosh S. Potential importance of Maackia amurensis agglutinin in non-small cell lung cancer. Biol Chem 2013; 394(7): 889-900. google scholar
  • 21. Chen J, Liu B, Ji N, Zhou J, Bian HJ, Li CY, Chen F, Bao JK, A novel sialic acid-specific lectin from Phaseolus coccineus seeds with potent antineoplastic and antifungal activities. Phytomedicine 2009; 16(4): 352-60. google scholar
  • 22. Liu Z, Liu B, Zhang ZT, Zhou TT, Bian HJ, Min MW, Liu YH, Chen J, Bao JK. A mannose-binding lectin from Sophora flavescens induces apoptosis in HeLa cells. Phytomedicine 2008; 15(10): 867-75. google scholar
  • 23. Hagiwara K, Collet-Cassart D, Kunihiko K, Vaerman JP. Jacalin: isolation, characterization, and influence of various factors on its interaction with human IgA1, as assessed by precipitation and latex agglutination. Mol Immunol 1988; 25(1): 69-83. google scholar
  • 24. Ahmed H, Chatterjee BP. Further characterization and immunochemical studies on the carbohydrate specificity of jackfruit (Artocarpus integrifolia) lectin. J Biol Chem 1989; 264(16): 9365-72. google scholar
  • 25. Yu LG, Milton JD, Fernig DG, Rhodes JM. Opposite effects on human colon cancer cell proliferation of two dietary Thomsen‐Friedenreich antigen‐binding lectins. J Cell Physiol 2001; 186(2): 282-7. google scholar
  • 26. Wang Q, Yu LG, Campbell BJ, Milton JD, Rhodes JM. Identification of intact peanut lectin in peripheral venous blood. Lancet 1998; 352(9143): 1831-2. google scholar
  • 27. Ochoa-Alvarez JA, Krishnan H, Pastorino JG, Nevel E, Kephart D, Lee JJ, Retzbach EP, Shen Y, Fatahzadeh M, Baredes S, Kalyoussef E. Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms. Oncotarget 2015; 6(11): 9045-60. google scholar
  • 28. Kolasińska E, Przybyło M, Janik M, Lityńska A. Towards understanding the role of sialylation in melanoma progression. Acta Biochim Pol 2016; 63(3): 533-41. google scholar
  • 29. Kaptan E, Sancar‐Bas S, Sancakli A, Bektas S, Bolkent S. The effect of plant lectins on the survival and malignant behaviors of thyroid cancer cells. J Cell Biochem 2018; 119(7): 6274-87. google scholar

Citations

Copy and paste a formatted citation or use one of the options to export in your chosen format


EXPORT



APA

Sancaklı, A., & Kaptan, E. (2019). Lectin Treatment Affects Malignant Characteristics of TPC-1 Papillary Thyroid Cancer Cells. European Journal of Biology, 78(1), 51-57. https://doi.org/10.26650/EurJBiol.2019.0006


AMA

Sancaklı A, Kaptan E. Lectin Treatment Affects Malignant Characteristics of TPC-1 Papillary Thyroid Cancer Cells. European Journal of Biology. 2019;78(1):51-57. https://doi.org/10.26650/EurJBiol.2019.0006


ABNT

Sancaklı, A.; Kaptan, E. Lectin Treatment Affects Malignant Characteristics of TPC-1 Papillary Thyroid Cancer Cells. European Journal of Biology, [Publisher Location], v. 78, n. 1, p. 51-57, 2019.


Chicago: Author-Date Style

Sancaklı, Aylin, and Engin Kaptan. 2019. “Lectin Treatment Affects Malignant Characteristics of TPC-1 Papillary Thyroid Cancer Cells.” European Journal of Biology 78, no. 1: 51-57. https://doi.org/10.26650/EurJBiol.2019.0006


Chicago: Humanities Style

Sancaklı, Aylin, and Engin Kaptan. “Lectin Treatment Affects Malignant Characteristics of TPC-1 Papillary Thyroid Cancer Cells.” European Journal of Biology 78, no. 1 (Dec. 2024): 51-57. https://doi.org/10.26650/EurJBiol.2019.0006


Harvard: Australian Style

Sancaklı, A & Kaptan, E 2019, 'Lectin Treatment Affects Malignant Characteristics of TPC-1 Papillary Thyroid Cancer Cells', European Journal of Biology, vol. 78, no. 1, pp. 51-57, viewed 19 Dec. 2024, https://doi.org/10.26650/EurJBiol.2019.0006


Harvard: Author-Date Style

Sancaklı, A. and Kaptan, E. (2019) ‘Lectin Treatment Affects Malignant Characteristics of TPC-1 Papillary Thyroid Cancer Cells’, European Journal of Biology, 78(1), pp. 51-57. https://doi.org/10.26650/EurJBiol.2019.0006 (19 Dec. 2024).


MLA

Sancaklı, Aylin, and Engin Kaptan. “Lectin Treatment Affects Malignant Characteristics of TPC-1 Papillary Thyroid Cancer Cells.” European Journal of Biology, vol. 78, no. 1, 2019, pp. 51-57. [Database Container], https://doi.org/10.26650/EurJBiol.2019.0006


Vancouver

Sancaklı A, Kaptan E. Lectin Treatment Affects Malignant Characteristics of TPC-1 Papillary Thyroid Cancer Cells. European Journal of Biology [Internet]. 19 Dec. 2024 [cited 19 Dec. 2024];78(1):51-57. Available from: https://doi.org/10.26650/EurJBiol.2019.0006 doi: 10.26650/EurJBiol.2019.0006


ISNAD

Sancaklı, Aylin - Kaptan, Engin. “Lectin Treatment Affects Malignant Characteristics of TPC-1 Papillary Thyroid Cancer Cells”. European Journal of Biology 78/1 (Dec. 2024): 51-57. https://doi.org/10.26650/EurJBiol.2019.0006



TIMELINE


Submitted11.04.2019
Accepted17.05.2019
Published Online31.05.2019

LICENCE


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


SHARE




Istanbul University Press aims to contribute to the dissemination of ever growing scientific knowledge through publication of high quality scientific journals and books in accordance with the international publishing standards and ethics. Istanbul University Press follows an open access, non-commercial, scholarly publishing.